• / Free eNewsletters & Magazine
  • / My Account
Home>New Normal … Morphing

New Normal … Morphing

Morningstar Articles

Tue, 14 May 2013

T. Rowe Price TROW reported solid second-quarter results Thursday. We're leaving our $32 fair value estimate unchanged. Assets under management rose $800 million from the prior quarter, as market depreciation largely offset inflows to T. Rowe's funds.

Related Videos

  1. Vaselkiv: Set the Right Expectations for High-Yield Bonds

    Favorable fundamentals and better yields relative to other fixed-income assets make high-yield bonds worthy of a long-term allocation, but investors shouldn't try to time the market and must ratchet down their return expectations, say T . Rowe Price High-Yield manager Mark Vaselkiv.

  2. When Managers Change, So Can Ratings

    Recent manager changes at T . Rowe and Janus resulted in Analyst Rating downgrades, says Morningstar's Russ Kinnel.

  3. 2 Muni Fund Picks That Sidestep Market Turbulence

    Fidelity Municipal Income and T . Rowe Price Tax-Free High Yield hold up well when muni markets head south.

  4. Giroux: Long-Term Focus, Concentration, Contrarianism Pay

    We're always willing to go where we see long-term value, but the market may not, says T . Rowe Price Capital Appreciation manager David Giroux.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.